These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3704946)

  • 1. [Treatment of chronic hepatitis patients with catergen].
    Karkishchenko NN; Okorokov AN; Fedorov NE; Laktionova AA; Sidorenko LF
    Ter Arkh; 1986; 58(2):76-9. PubMed ID: 3704946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L; Dávid K; Nagy I; Stotz G; Kelemen JT
    Acta Physiol Hung; 1984; 64(3-4):461-70. PubMed ID: 6152370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A; Paál M; Kádas I; Kerekes E; Jávor T
    Acta Med Hung; 1983; 40(1):17-24. PubMed ID: 6664741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M; Kisfaludy S; Szalay F
    Acta Physiol Hung; 1984; 64(3-4):455-60. PubMed ID: 6397971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences with Catergen treatment in chronic active hepatitis.
    Pár A; Paál M; Kádas I; Nagy I; Kerekes E; Jávor T
    Ther Hung; 1983; 31(3):105-14. PubMed ID: 6400472
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of cyanidanol-3 on lysosomal enzyme activity of serum and granulocytes in chronic liver disease and active hepatitis.
    Fehér J; Toncsev H; Sréter L; Cornides A; Kiss A
    Int J Tissue React; 1984; 6(1):75-80. PubMed ID: 6715121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
    Tamarkina AD; Neverov IV; Turitsyna IG; Dement'eva ES; Krylova NI
    Sov Med; 1985; (12):26-30. PubMed ID: 4095626
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of therapeutic effect of catergen in viral hepatitis].
    Boroń P; Boroń-Kaczmarska A; Sokolewicz-Bobrowska E; Szpakowicz T; Nadowska K
    Pol Tyg Lek; 1979 Aug; 34(33):1315-7. PubMed ID: 117435
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)].
    Vido I; Schmidt FW; Müller R; Ranft U; Wildhirt E; Holzer E; Wallnöfer H; Korb G
    Dtsch Med Wochenschr; 1980 Mar; 105(10):330-2. PubMed ID: 6153953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
    Pfliegler G; Boda Z; Dalmi L; Weisz G; Misz M; Beck P
    Ther Hung; 1984; 32(1):19-25. PubMed ID: 6571189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical analysis of 4 cases of severe viral hepatitis treated with catergen].
    Rzeszowska G; Modrzewska R; Radomińska I
    Wiad Lek; 1980 May; 33(9):739-43. PubMed ID: 7405243
    [No Abstract]   [Full Text] [Related]  

  • 14. ["Catergen" in the treatment of hepatitis].
    Gładysz A; Juszczyk J
    Wiad Lek; 1985 Jul; 38(14):1039-42. PubMed ID: 3907149
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
    Pár A; Horváth T; Beró T; Kádas I; Pakodi F; Jávor T
    Acta Physiol Hung; 1984; 64(3-4):449-54. PubMed ID: 6152369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of Catergen (ZYMA) in the treatment of viral hepatitis].
    Rzeszowska G; Patorska-Mach E; Mierzejewska I; Radomińska I; Modrzewska R; Pomorska M
    Pol Tyg Lek; 1981 Mar; 36(9):327-9. PubMed ID: 7022412
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of catergen on the course of acute viral hepatitis].
    Babiuch L; Poznańska H; Rychalska B
    Przegl Epidemiol; 1981; 35(4):471-7. PubMed ID: 6803308
    [No Abstract]   [Full Text] [Related]  

  • 18. [The value of Catergen].
    Orv Hetil; 1983 Jun; 124(23):1411-2. PubMed ID: 6877819
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary evaluation of catergen (Zyma) in the treatment of acute viral hepatitis (author's transl)].
    Sowa J; Odrobina S; Mossor-Ostrowska J
    Przegl Lek; 1980; 37(7):573-7. PubMed ID: 6997933
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ; Borg R
    Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.